According to the CITIC Construction Investment Research Report, due to factors such as the collection of consumables and increased medical compliance requirements, the A-share Shenwan Medical Device Index continued to decline from 2021 to 2024, rising and then falling in 2025, then rebounding in early 2026 and then falling. As the impact of policies is gradually clarified, and performance gradually recovers after corporate strategy adjustments, the medical device sector is undergoing both valuation and performance restoration. Companies that focus on performance growth and continuous improvement in 2027 are expected to double down on performance valuation in the future. It is expected that the impact of procurement and price reduction policies in several high-value consumables and IVD sectors will gradually clear up by the end of the year or the beginning of next year, and sector-based investment opportunities will gradually become prominent.

According to the CITIC Construction Investment Research Report, due to factors such as the collection of consumables and increased medical compliance requirements, the A-share Shenwan Medical Device Index continued to decline from 2021 to 2024, rising and then falling in 2025, then rebounding in early 2026 and then falling. As the impact of policies is gradually clarified, and performance gradually recovers after corporate strategy adjustments, the medical device sector is undergoing both valuation and performance restoration. Companies that focus on performance growth and continuous improvement in 2027 are expected to double down on performance valuation in the future. It is expected that the impact of procurement and price reduction policies in several high-value consumables and IVD sectors will gradually clear up by the end of the year or the beginning of next year, and sector-based investment opportunities will gradually become prominent.